Home LiteratureArticle Details
PMID: 8598494 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Regulation of NF-kappa B activation in T helper 1 and T helper 2 cells.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 156 ·No. 1 ·1996-01-01 ·Pages 56-63

Lederer JA, Liou JS, Kim S, Rice N, Lichtman AH

Abstract

In most cell types, NF-kappa B is activated by release from a cytoplasmic inhibitor protein, I kappa B, followed by its translocation to the nucleus where it binds to the regulatory regions of many genes, including the IL-2 gene in T lymphocytes. We have previously shown by electrophoretic mobility shift assays that nuclear extracts prepared from activated, non-IL-2-producing Th2 cell clones. We show here that Th-1 and Th2 cells have similar levels of cytoplasmic p65(RelA) and p50, but TCR stimulation fails to induce the nuclear translocation of p65(RelA) in Th2 cells. Nuclear translocation of p65(RelA) can be induced by IL-1 stimulation of Th2 cells, indicating that a basic mechanism of NF-Kappa B activation common to many cells is intact in Th2 cells. We demonstrate that IL-1 and TNF induce rapid nuclear translocation of p65(RelA) in T cell clones, whereas TCR-induced NF-Kappa B activation in Th1 cells is delayed and may be longer in duration. This suggests that the TCR pathway of NF-Kappa B activation is different from the cytokine pathway. Furthermore, we show that Th1 and Th2 cells express different levels and/or different forms of I kappa B alpha, and that cytokines, but not TCR stimuli, significantly modulate detectable levels of cytoplasmic I kappa B alpha.

MeSH Terms
Animals Blotting, Northern Cell Line Cell Nucleus/metabolism Gene Expression Regulation/drug effects Interleukin-1/pharmacology Interleukin-2/genetics Ionomycin/pharmacology Lymphocyte Activation/drug effects Mice NF-kappa B/metabolism Phosphoproteins/metabolism Tetradecanoylphorbol Acetate/pharmacology Th1 Cells/drug effects,immunology,metabolism Th2 Cells/drug effects,immunology,metabolism Transcription Factor RelA Tumor Necrosis Factor-alpha/pharmacology
Chemicals
Interleukin-1 Interleukin-2 NF-kappa B Phosphoproteins Transcription Factor RelA Tumor Necrosis Factor-alpha lymphocyte-specific protein p50 Ionomycin Tetradecanoylphorbol Acetate
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Lederer J A
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.
Liou J S
Kim S
Rice N
Lichtman A H
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1996-01-01
Pages
56-63
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NHLBI NIH HHS · HL07627 · United States
NCI NIH HHS · N01-CO-74101 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com